Eli Lilly to license rheumatoid drug-making technology to Egypt’s EVA
Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to.
Drugs
Health
Pharma
Drugs
Health
Pharma
Body undergoes tectonic molecular shifts at age 44, 60: Stanford Medicine
Molecules and microorganisms in the human body dramatically rise or fall at an average age of 44 and 60 affecting both the heart.
Drugs
Health
Pharma
J&J plans to acquire Israel’s V-Wave by paying $600 million upfront
Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the.
Drugs
Health
Pharma
Alcohol claims 2.6 million lives yearly, 209m people are dependent: WHO
About 400 million people globally live with alcohol and drug use disorders and of the total, 209 million people have alcohol dependence, according.
Drugs
Health
Pharma
Opinion: Feast for G20 leaders, benefits of millets exceed rice, wheat
By Dr. K. Leelamoni November 30, 2023: The move to serve Indian millet-based food, to G20 leaders in New Delhi in September 2023.
Drugs
Health
Pharma
Novo Nordisk stops testing of Ozempic as kidney trial meets efficacy goals
HQ Team October 11, 2023: Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people.
Drugs
Health
Pharma
FDA approves Lexicon’s oral drug for heart failure, type 2 diabetes patients
INPEFA is an inhibitor of both sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1). This class of SGLT inhibitors was recommended as.